Nearly 900 million adults around the world are living with obesity, which is a substantial risk factor for at least 20 diseases or conditions that include diabetes, cardiovascular conditions, and brain health disorders. The McKinsey Health Institute (MHI) estimates that obesity will be linked to $2.76 trillion in lost gross domestic product in 2050 due to its effects on labor force participation and productivity. The rise of GLP-1s is shifting the discussion of obesity from an intractable issue to a treatable medical condition—a change that is inspiring investment and innovation across industries, including healthcare, medtech, food, and retail. Society has two possible paths forward.
Read the full article: The Path Toward a Metabolic Health Revolution //
Source: https://www.mckinsey.com/mhi/our-insights/the-path-toward-a-metabolic-health-revolution